For the Culture By The Culture
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
A new Telegraph article claims cannabis gummies could damage your heart, but the science doesn’t back the hysteria. We take their claims apart and show how fear-mongering headlines continue to distort cannabis facts. At a time when real education is needed, sensationalist reporting is the real threat.
A massive new meta-analysis reviewed over 10,000 cannabis-related cancer studies and found that nearly 75% showed therapeutic benefit. From nausea relief to potential tumor suppression, the science is no longer fringe. This isn’t a breakthrough—it’s a reckoning with decades of delay, stigma, and denial. The question now is: what’s still standing in the way?
Another study, another misleading headline. The media is at it again, twisting nuanced cannabis research into fear-mongering clickbait. Here’s what The Independent got wrong—and why this keeps happening
Cannabis legalization has rapidly advanced, with significant increases in use and a growing market for high-THC products. However, research and policy developments lag behind, posing risks to public health. While equity initiatives exist, a comprehensive approach is needed to ensure safety and accountability in the cannabis industry, prioritizing informed consumer protection.
Cannabis use is rising among people with diabetes, but research is still unclear about the overall effects. Some say it helps manage stress and pain, while others see worsened glucose control. As the stigma falls, it’s more important than ever to understand the real risks and benefits. We cut through the noise and keep it real
